Brexit – Indian Pharma’s Diversified Play A Buffer?
This article was originally published in PharmAsia News
Indian markets slumped on June 24 after the UK voted to exit the EU, though industry experts had mixed views on how things may pan out for Indian drug firms with an exposure in Britain or Europe as a whole. Most concurred only that there would be turbulence in the currency markets in the short term.
Register for our free email digests: